rs121434287
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The ENST00000301305.8(SLC39A4):c.599C>T(p.Pro200Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,613,194 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P200P) has been classified as Likely benign.
Frequency
Consequence
ENST00000301305.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A4 | NM_130849.4 | c.599C>T | p.Pro200Leu | missense_variant | 3/12 | ENST00000301305.8 | NP_570901.3 | |
LOC124902041 | XR_007061145.1 | n.764G>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A4 | ENST00000301305.8 | c.599C>T | p.Pro200Leu | missense_variant | 3/12 | 1 | NM_130849.4 | ENSP00000301305 | P1 | |
SLC39A4 | ENST00000276833.9 | c.524C>T | p.Pro175Leu | missense_variant | 2/11 | 2 | ENSP00000276833 | |||
SLC39A4 | ENST00000526658.1 | c.317C>T | p.Pro106Leu | missense_variant | 2/4 | 3 | ENSP00000434512 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000128 AC: 32AN: 249864Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135524
GnomAD4 exome AF: 0.000181 AC: 264AN: 1460920Hom.: 0 Cov.: 34 AF XY: 0.000180 AC XY: 131AN XY: 726776
GnomAD4 genome AF: 0.000144 AC: 22AN: 152274Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74458
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 200 of the SLC39A4 protein (p.Pro200Leu). This variant is present in population databases (rs121434287, gnomAD 0.02%). This missense change has been observed in individual(s) with acrodermatitis enteropathica (PMID: 12068297, 12955721). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3537). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SLC39A4 function (PMID: 14709598, 31979155). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 16, 2023 | Functional studies indicate P200L affects the uptake of zinc and suggests the function of the protein may be impaired, with the availability of the protein at the plasma membrane also affected (Wang et al., 2004; Kambe et al., 2009); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19370757, 17483098, 27321477, 12068297, 18936158, 16819703, 28717982, 31979155, 33837739, 31589614, 33889411, 12955721, 14709598) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2022 | - - |
Hereditary acrodermatitis enteropathica Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2002 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 14, 2022 | - - |
SLC39A4-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 26, 2023 | The SLC39A4 c.599C>T variant is predicted to result in the amino acid substitution p.Pro200Leu. This variant was reported in the homozygous and compound heterozygous states in individuals with acrodermatitis enteropathica, including in multiple affected individuals from the same family (Families E and F, Kury et al. 2002. PubMed ID: 12068297; Families E and F previously reported by this group and Patient S-28, Kury et al. 2003. PubMed ID: 12955721; Patient previously reported by this group as Patient S-28, Lehnert et al. 2006. PubMed ID: 16819703). Functional studies in mouse models showed that this variant lead to wild-type levels of protein accumulation, however it was associated with increased accumulation of smaller molecular mass forms of protein (Wang et al. 2004. PubMed ID: 14709598). Additional studies in mouse models also showed that this variant had a modest impact on protein function and was overall similar to that of wild-type function (Wang et al. 2004. PubMed ID: 14709598). Additional functional studies using human embryonic kidney cells have conflicting results on the impact of the p.Pro200Leu variant on protein function (Hoch and Hershfinkel. 2020. PubMed ID: 31979155; Kuliyev and Sui. 2021. PubMed ID: 33837739). This variant is reported in 0.020% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-145640679-G-A) and is interpreted as likely pathogenic by several outside laboratories in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/3537/). Taken together, we interpret this variant as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at